Helicobacter hepaticus promotes azoxymethane‐initiated colon tumorigenesis in BALB/c‐IL10‐deficient mice
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The BALB/c‐IL10 null mouse strain develops colitis and colitis‐associated adenocarcinomas, and is a model for idiopathic inflammatory bowel disease. We tested the hypotheses that (i) azoxymethane (AOM), a carcinogen that targets the colon, synergizes with the colonic inflammation inherent in the BALB/c‐IL10 null mouse resulting in an increase in incidence, multiplicity and/or progression of AOM‐induced tumors or colitis‐associated adenocarcinomas; and (ii) prior infection with Helicobacter hepaticus, a common enterohepatic bacterial pathogen in many research mouse colonies, increases the incidence, multiplicity and/or progression of AOM‐induced colon tumors or colitis‐associated adenocarcinomas in the BALB/c‐IL10 null mouse. We show that, within the timeframe examined, AOM‐induced colon tumors in the BALB/c‐IL10 null mouse were grossly and microscopically similar in appearance to AOM‐induced colon tumors in the wild type BALB/cJ mouse. No colitis‐associated adenocarcinomas were identified. Infection with H. hepaticus prior to AOM‐treatment also did not result in colitis‐associated adenocarcinomas but did result in a significant increase in the incidence of AOM‐induced colon tumors relative to AOM treatment alone. The AOM‐induced adenomas were predominantly exophytic and nodular or polypoid and localized to the distal colon. These results suggest that H. hepaticus promotes AOM‐induced tumorigenesis in the BALB/c‐IL10 null mouse. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Cited by
High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122308 · Cited by 529
“Mice were fed 3× on consecutive days with Hh 1A (1.0 × 108 CFU) by oral gavage and injected with AOM (Sigma-Aldrich) i.p. once a week at a dose of 10 mg/kg for 5 wk, starting 6 wk after Hh infection (Nagamine et al., 2008).”
BackgroundMethodInfluentialLong-lived intestinal tuft cells serve as colon cancer–initiating cells
Westphalen, C. B., Asfaha, S., Hayakawa, Y., Takemoto, Y., Lukin, D. J., Nuber, A. H., Brandtner, A., Setlik, W., Remotti, H., Muley, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73434 · Cited by 389
Self-citationGastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Overacre-Delgoffe, A. E., Bumgarner, H. J., Cillo, A. R., Burr, A. H. P., Tometich, J. T., Bhattacharjee, A., Bruno, T. C., Vignali, D. A. A., & Hand, T. W. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.003 · Cited by 318
Beneficial bacteria inhibit cachexia
Varian, B. J., Goureshetti, S., Poutahidis, T., Lakritz, J. R., Levkovich, T., Kwok, C., Teliousis, K., Ibrahim, Y. M., Mirabal, S., & Erdman, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7730 · Cited by 146
“Several lines of evidence implicate GI tract microbiota stimulating neutrophils and other cells of innate immune cells leading to tumor formation throughout the body [11, 49, 58-64].”
Background
Metadata
- Authors
- Nagamine, C. M., Rogers, A. B., Fox, J. G., & Schauer, D. B.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-10-23
- Volume
- 122
- Issue
- 4
- Pages
- 832-838
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1988424412
- Cited by
- 64
- References
- 1
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.